|
American Joint Committee on Cancer (AJCC) TNM and FIGO Staging System for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (8th ed., 2017) 卵巢癌、输卵管癌和原发性腹膜癌TNM分期 和 FIGO分期2017年8版 TNM | FIGO |
| TX |
| Primary tumor cannot be assessed 原发肿瘤不可评估 | T0 |
| No evidence of primary tumor 没有原发肿瘤 | T1 | Ⅰ | Tumor limited to ovaries (one or both) or fallopian tube(s) 肿瘤局限于卵巢（单侧或者双侧）或者输卵管。 | T1a | ⅠA | Tumor limited to one ovary (capsule intact) or fallopian tube, no tumor on ovarian or fallopian tube surface; no malignant cells in ascites or peritoneal washings 肿瘤局限于单侧卵巢（囊壁完好）或输卵管，并且卵巢和输卵管表面无肿瘤，并且腹水或者腹腔冲洗液无肿瘤细胞。 | T1b | ⅠB | Tumor limited to both ovaries; (capsules intact) or fallopian tubes; no tumor on ovarian or fallopian tube surface; no malignant cells in ascites or peritoneal washings 肿瘤局限于双侧卵巢（囊壁完好）或输卵管，并且卵巢和输卵管表面无肿瘤，并且腹水或者腹腔冲洗液无肿瘤细胞。 | T1c | ⅠC | Tumor limited to one or both ovaries or fallopian tubes, with any of the following: 肿瘤局限于单侧或双侧卵巢或者输卵管，合并以下任一情况： | T1c1 | ⅠC1 | Surgical spill 术中肿瘤破裂 | T1c2 | ⅠC2 | Capsule ruptured before surgery or tumor on ovarian or fallopian tube surface 术前肿瘤自发破裂，或者卵巢或输卵管表面有肿瘤 | T1c3 | ⅠC3 | Malignant cells in ascites or peritoneal washings 腹水或腹腔冲洗液有恶性细胞（细胞学阳性） | T2 | Ⅱ | Tumor involves one or both ovaries or fallopian tubes with pelvic extension below pelvic brim or primary peritoneal cancer 肿瘤累及单侧或双侧卵巢或输卵管，伴盆腔内扩散未超出盆腔上缘或者原发性腹膜癌（局限于盆腔内） | T2a | ⅡA | Extension and/or implants on the uterus and/or fallopian tube(s) and/or ovaries 子宫和/或输卵管和/或卵巢的扩散和/或种植（未超出子宫双附件） | T2b | ⅡB | Extension to and/or implants on other pelvic tissues 扩散和/或种植到盆腔内其他组织（超出子宫双附件） | T3 | Ⅲ | Tumor involves one or both ovaries or fallopian tubes, or primary peritoneal cancer, with microscopically confirmed peritoneal metastasis outside the pelvis and/or metastasis to the retroperitoneal (pelvic and/or para-aortic) lymph nodes 肿瘤累及一侧或双侧卵巢或输卵管，或原发性腹膜癌，伴有镜下证实的盆腔外腹膜转移和/或腹膜后(盆腔和/或腹主动脉旁)淋巴结转移 （肿瘤累及盆腔以外） | T1/T2 N1 | ⅢA1 | Positive retroperitoneal lymph nodes only (histologically confirmed) 仅腹膜后阳性淋巴结(组织学证实) | T1/T2 N1a | ⅢA1i | Metastasis up to and including 10 mm in greatest dimension 仅腹膜后淋巴结阳性，病灶最大直径≤10mm | T1/T2 N1b | ⅢA1ii | Metastasis more than 10 mm in greatest dimension 仅腹膜后淋巴结阳性，病灶最大直径＞10mm | T3a | ⅢA2 | Microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes 镜下肿瘤超出盆腔腹膜（骨盆上缘以上），伴或不伴腹膜后淋巴结阳性 | T3b | ⅢB | Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension with or without metastasis to the etroperitoneal lymph nodes 盆腔外腹膜肉眼可见肿瘤转移灶，最大直径≤2cm，伴或不伴腹膜后淋巴结转移 | T3c | ⅢC | Macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ) 盆腔外腹膜可见肿瘤转移灶最大直径＞2cm，伴或不伴腹膜后淋巴结转移（包括肝包膜、脾包膜的肿瘤，没有任何脏器实质的受累。） | M1 | Ⅳ | Distant metastasis, including pleural effusion with positive cytology; liver or splenic parenchymal metastasis; metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); and transmural involvement of intestine 远处转移，包括胸腔积液细胞学阳性、肝或脾实质转移、转移至腹腔外脏器（包括腹股沟淋巴结和腹腔以外的淋巴结）、肠道的透壁侵犯。 | M1a | ⅣA | Pleural effusion with positive cytology 胸腔积液细胞学阳性 | M1b | ⅣB | Liver or splenic parenchymal metastases; metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); transmural involvement of intestine 肝或脾实质转移、转移至腹腔外脏器（包括腹股沟淋巴结和腹腔以外的淋巴结）、肠道的透壁侵犯 |
|
